{"id":"W2550077017","doi":"10.1182/blood.v116.21.3432.3432","title":"Pharmacokinetics of Dasatinib as a First Line Therapy In Newly Diagnosed CML Patients (OPTIM dasatinib trial): Correlation with Safety and Response.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Dasatinib; Cmin; Medicine; Cmax; Internal medicine; Pharmacokinetics; Adverse effect; Dosing; Tyrosine-kinase inhibitor; Gastroenterology; Pharmacology; Oncology; Tyrosine kinase; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001396714,0.0003734804,0.001263889,0.0001875651,0.0001139987,0.0006822772,0.0003171473,0.000509989,0.001071931],"category_scores_gemma":[0.001597137,0.0002303353,0.0006200789,0.0002583262,0.0003053652,0.0004671768,0.0002275303,0.001014077,0.0002557122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004840096,"about_ca_system_score_gemma":0.0003448979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002104263,"about_ca_topic_score_gemma":0.0004612243,"domain_scores_codex":[0.9994944,0.0002327724,0.00004042256,0.0001104484,0.0000823739,0.00003960025],"domain_scores_gemma":[0.9990354,0.0002207327,0.0004237758,0.00006302603,0.00003418303,0.000222949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7225358,0.003524679,0.1173776,0.001029029,0.002280943,0.000273147,0.0001970857,0.005204089,0.03577954,0.0002486684,0.004470643,0.1070788],"study_design_scores_gemma":[0.3103305,0.1467901,0.5122404,0.0001061801,0.002326464,0.002150091,0.0000629249,0.008343136,0.01013715,0.000592004,0.00679635,0.0001247484],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929039,0.004235339,0.0002839514,0.0002337699,0.00003446522,0.0002296515,0.0008740428,0.00003738839,0.001167573],"genre_scores_gemma":[0.9964405,0.0007127763,0.000503013,0.0001626916,0.00005934749,0.000147474,0.001505446,0.000008267901,0.000460473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001396714,"threshold_uncertainty_score":0.007386625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01221632495188872,"score_gpt":0.2732422933148279,"score_spread":0.2610259683629391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}